Recurrent ETNK1 mutations in atypical chronic myeloid leukemia

Blood

Volumn 125, Issue 3, 2015, Pages 499-503

  Gambacorti Passerini, Carlo B ^a,b   Donadoni, Carla ^a   Parmiani, Andrea ^a   Pirola, Alessandra ^a   Redaelli, Sara ^a   Signore, Giovanni ^c   Piazza, Vincenzo ^c   Malcovati, Luca ^d   Fontana, Diletta ^a   Spinelli, Roberta ^a   Magistroni, Vera ^a   Gaipa, Giuseppe ^a   Peronaci, Marco ^a   Morotti, Alessandro ^e   Panuzzo, Cristina ^e   Saglio, Giuseppe ^e   Usala, Emilio ^f   Kim, Dong Wook ^g   Rea, Delphine ^h   Zervakis, Konstantinos ⁱ   Viniou, Nora ⁱ   Symeonidis, Argiris ^j   Becker, Heiko ^k   Boultwood, Jacqueline ^l   Campiotti, Leonardo ^m   Carrabba, Matteo ⁿ   Elli, Elena ^b   Bignell, Graham R ^o   Papaemmanuil, Elli ^o   Campbell, Peter J ^o   Cazzola, Mario ^d   Piazza, Rocco ^a   more..

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c CENTER FOR NANOTECHNOLOGY INNOVATION NEST   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF TURIN   (Italy)

^f Ospedale Oncologico A Businco   (Italy)

^g The Catholic University of Korea   (South Korea)

^h SAINT LOUIS HOSPITAL   (France)

ⁱ UNIVERSITY OF ATHENS   (Greece)

^j UNIVERSITY OF PATRAS   (Greece)

^k UNIVERSITY OF FREIBURG   (Germany)

^l JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^m UNIVERSITY OF INSUBRIA   (Italy)

ⁿ SAN RAFFAELE HOSPITAL   (Italy)

^o WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ETHANOLAMINE KINASE; ETHANOLAMINE KINASE 1; PHOSPHOETHANOLAMINE; PHOSPHORYLCHOLINE; PHOSPHOTRANSFERASE; UNCLASSIFIED DRUG;

ARTICLE; ATYPICAL CHRONIC MYELOID LEUKEMIA; CATALYSIS; CELL LINE; CHRONIC MYELOMONOCYTIC LEUKEMIA; CLONE; CONTROLLED STUDY; DOMINANT GENE; ENZYME ACTIVITY; ENZYME INHIBITION; GENE IDENTIFICATION; GENE SEQUENCE; GENETIC VARIABILITY; HEMATOLOGIC DISEASE; HETEROZYGOTE; HUMAN; MAJOR CLINICAL STUDY; MISSENSE MUTATION; MYELODYSPLASTIC SYNDROME; MYELOPROLIFERATIVE DISORDER; NONSENSE MUTATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SOMATIC MUTATION; TF1 CELL; AMINO ACID SEQUENCE; CASE CONTROL STUDY; CHRONIC MYELOID LEUKEMIA; COMPARATIVE STUDY; FOLLOW UP; GENETICS; MOLECULAR GENETICS; MUTATION; PROGNOSIS; SEQUENCE HOMOLOGY;

AMINO ACID SEQUENCE; CASE-CONTROL STUDIES; FOLLOW-UP STUDIES; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; LEUKEMIA, MYELOMONOCYTIC, CHRONIC; MOLECULAR SEQUENCE DATA; MUTATION; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); PROGNOSIS; SEQUENCE HOMOLOGY, AMINO ACID;

EID: 84922213806     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2014-06-579466     Document Type: Article

References (25)

1. Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009;114(5):937-951.
2. Vardiman J, Hyjek E. World health organization classification, evaluation, and genetics of the myeloproliferative neoplasm variants. Hematology Am Soc Hematol Educ Program. 2011;2011:250-256.
3. Piazza R, Valletta S, Winkelmann N, et al. Recurrent SETBP1 mutations in atypical chronic myeloid leukemia. Nat Genet. 2013;45(1):18-24.
4. Meggendorfer M, Bacher U, Alpermann T, et al. SETBP1 mutations occur in 9% of MDS/MPN and in 4% of MPN cases and are strongly associated with atypical CML, monosomy 7, isochromosome i(17)(q10), ASXL1 and CBL mutations. Leukemia. 2013;27(9):1852-1860.
5. Flora F, Pirola A, Spinelli R, et al. SAM-Profiler: A Graphical Tool for Qualitative Profiling of Next Generation Sequencing Alignment Data. J Comput Sci Syst Biol. 2013;6:188-193.
6. Piazza R, Magistroni V, Pirola A, et al. CEQer: a graphical tool for copy number and allelic imbalance detection from whole-exome sequencing data. PLoS ONE. 2013;8(10):e74825.
7. Piazza R, Pirola A, Spinelli R, et al. FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery. Nucleic Acids Res. 2012;40(16):e123.
8. Spinelli R, Pirola A, Redaelli S, et al. Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases. Mol Genet Genomic Med. 2013;1(4):246-259.
9. Koc H, Mar MH, Ranasinghe A, Swenberg JA, Zeisel SH. Quantitation of choline and its metabolites in tissues and foods by liquid chromatography/electrospray ionization-isotope dilution mass spectrometry. Anal Chem. 2002;74(18):4734-4740.
10. Maxson JE, Gotlib J, Pollyea DA, et al. Oncogenic CSF3R mutations in chronic neutrophilic leukemia and atypical CML. N Engl J Med. 2013;368(19):1781-1790.
11. Gotlib J, Maxson JE, George TI, Tyner JW. The new genetics of chronic neutrophilic leukemia and atypical CML: implications for diagnosis and treatment. Blood. 2013;122(10):1707-1711.
12. Simossis VA, Kleinjung J, Heringa J. Homology-extended sequence alignment. Nucleic Acids Res. 2005;33(3):816-824.
13. Behjati S, Tarpey PS, Sheldon H, et al. Recurrent PTPRB and PLCG1 mutations in angiosarcoma. Nat Genet. 2014;46(4):376-379.
14. Behjati S, Tarpey PS, Presneau N, et al. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nat Genet. 2013;45(12):1479-1482.
15. Tarpey PS, Behjati S, Cooke SL, et al. Frequent mutation of the major cartilage collagen gene COL2A1 in chondrosarcoma. Nat Genet. 2013;45(8):923-926.
16. Bolli N, Avet-Loiseau H, Wedge DC, et al. Heterogeneity of genomic evolution and mutational profiles in multiple myeloma. Nat Commun. 2014;5:2997.
17. Papaemmanuil E, Rapado I, Li Y, et al. RAG-mediated recombination is the predominant driver of oncogenic rearrangement in ETV6-RUNX1 acute lymphoblastic leukemia. Nat Genet. 2014;46(2):116-125.
18. Stephens PJ, Tarpey PS, Davies H, et al; Oslo Breast Cancer Consortium (OSBREAC). The landscape of cancer genes and mutational processes in breast cancer. Nature. 2012;486(7403):400-404.
19. Varela I, Tarpey P, Raine K, et al. Exome sequencing identifies frequent mutation of the SWI/SNF complex gene PBRM1 in renal carcinoma. Nature. 2011;469(7331):539-542.
20. Kennedy EP, Weiss SB. The function of cytidine coenzymes in the biosynthesis of phospholipides. J Biol Chem. 1956;222(1):193-214.
21. Furt F, Moreau P. Importance of lipid metabolism for intracellular and mitochondrial membrane fusion/fission processes. Int J Biochem Cell Biol. 2009;41(10):1828-1836.
22. Birner R, Bürgermeister M, Schneiter R, Daum G. Roles of phosphatidylethanolamine and of its several biosynthetic pathways in Saccharomyces cerevisiae. Mol Biol Cell. 2001;12(4):997-1007.
23. Mileykovskaya E, Dowhan W. Role of membrane lipids in bacterial division-site selection. Curr Opin Microbiol. 2005;8(2):135-142.
24. Papaemmanuil E, Gerstung M, Malcovati L, et al; Chronic Myeloid Disorders Working Group of the International Cancer Genome Consortium. Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood. 2013;122(22):3616-3627, quiz 3699.
25. Cazzola M, Della Porta MG, Malcovati L. The genetic basis of myelodysplasia and its clinical relevance. Blood. 2013;122(25):4021-4034.